CRISPR/Cas9‐mediated disruption of lipocalins , Ly6g5b , and Ly6g5c causes male subfertility in mice
Andrology · 2024-07 · 12 (5) · 981-990
DOI: 10.1111/andr.13350 ↗At a glance
Journal article in Andrology, published online on 2022-12-10. Written by Nobuyuki Sakurai and 3 co-authors. Institution: Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Major MEDLINE topics: Antigens, Ly, CRISPR-Cas Systems, Infertility, Male, Lipocalins. Cited 13 times so far (Crossref); 33 references. The full text is freely available in PubMed Central. Funded by: Senri Life Science Foundation, NICHD NIH HHS, National Cerebral and Cardiovascular Center.
Abstract (original language)
Background
Spermatozoa become mature and competent for fertilization during transit from the caput epididymis to the cauda epididymis. However, detailed molecular mechanisms of epididymal sperm maturation are still unclear. Here, we focused on multiple epididymis‐enriched genes: lipocalin family genes ( Lcn5 , Lcn6 , Lcn8 , Lcn9 , and Lcn10 ) and Ly6 family genes ( Ly6g5b and Ly6g5c ). These genes are evolutionarily conserved in mammals and form clusters on chromosomes 2 and 17 in the mouse, respectively.
Objective
To clarify whether these genes are required for epididymal sperm maturation and acquisition of fertilizing ability, we generated knockout (KO) mice using the CRISPR/Cas9 system and analyzed their phenotype. Materials and methods We generated four lines of KO mice: Lcn9 single KO, the lipocalin family quadruple KO ( Lcn5 , Lcn6 , Lcn8 , and Lcn10 ), quintuple KO ( Lcn5 , Lcn6 , Lcn8 , Lcn10 , and Lcn9 ), and double KO of Ly6 family genes ( Ly6g5b and Ly6g5c ).
Results
Although the Lcn9 single KO did not affect male fertility, the quadruple KO and quintuple KO male mice were subfertile and mostly infertile, respectively, with a reduced amount of ADAM3, an essential protein for sperm binding to the zona pellucida. Further analysis revealed that the quintuple KO spermatozoa lack the CMTM2A/B that are required for ADAM3 maturation. Intriguingly, Ly6g5b and Ly6g5c double KO male mice also showed subfertility with reduced sperm ADAM3.
Conclusion
These results suggest epididymal secretory proteins are involved in ADAM3 maturation and acquisition of sperm fertilizing ability.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
- Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
- Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
- Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
- The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
ORCID profiles: Yoshitaka Fujihara, Masahito Ikawa
Funding
- Senri Life Science Foundation
- NICHD NIH HHS
- National Cerebral and Cardiovascular Center
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Sumitomo Foundation
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Cite
APA
Sakurai, N., Fujihara, Y., Kobayashi, K., & Ikawa, M. (2024). CRISPR/Cas9‐mediated disruption of lipocalins , Ly6g5b , and Ly6g5c causes male subfertility in mice. Andrology, 12(5), 981-990. https://doi.org/10.1111/andr.13350
Vancouver
Sakurai N, Fujihara Y, Kobayashi K, Ikawa M. CRISPR/Cas9‐mediated disruption of lipocalins , Ly6g5b , and Ly6g5c causes male subfertility in mice. Andrology. 2024;12(5):981-990. doi:10.1111/andr.13350
BibTeX
@article{Sakurai2024,
author = {Sakurai, Nobuyuki and Fujihara, Yoshitaka and Kobayashi, Kiyonori and Ikawa, Masahito},
title = {CRISPR/Cas9‐mediated disruption of lipocalins , Ly6g5b , and Ly6g5c causes male subfertility in mice},
journal = {Andrology},
year = {2024},
volume = {12},
number = {5},
pages = {981--990},
doi = {10.1111/andr.13350}
}
EUVIMED